Biomerica, Inc.
BMRA
$3.88
$0.123.19%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.85M | -5.61M | -6.16M | -5.98M | -6.35M |
| Total Depreciation and Amortization | 393.00K | 388.00K | 379.00K | 374.00K | 360.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 490.00K | 753.00K | 686.00K | 622.00K | 967.00K |
| Change in Net Operating Assets | -257.00K | -516.00K | 66.00K | -379.00K | -258.00K |
| Cash from Operations | -4.22M | -4.98M | -5.03M | -5.36M | -5.28M |
| Capital Expenditure | -24.00K | -24.00K | -30.00K | -51.00K | -27.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -37.00K | -49.00K | -22.00K | -64.00K | -78.00K |
| Cash from Investing | -61.00K | -73.00K | -52.00K | -115.00K | -105.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.16M | 392.00K | -- | -- | 8.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -124.00K | -93.00K | -81.00K | -81.00K | -652.00K |
| Cash from Financing | 2.04M | 299.00K | -81.00K | -81.00K | 7.35M |
| Foreign Exchange rate Adjustments | -11.00K | -8.00K | -4.00K | 8.00K | 9.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.26M | -4.76M | -5.17M | -5.55M | 1.97M |